SCHEMBL2183221

SCHEMBL2183221

COc1cc(NC(=O)C=Cc2ccc(OC)c(Br)c2)c(OC)cc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.60
HPGD P15428 7/20 0.59
ALDH1A1 P00352 7/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
NPSR1 Q6W5P4 2/20 0.59
KDM4E B2RXH2 5/20 0.55
MAPT P10636 4/20 0.54
TP53 P04637 3/20 0.54
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
CYP3A4 P08684 2/20 0.53
HIF1A Q16665 2/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
PKM P14618 2/20 0.53
MAPK1 P28482 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2183218 1.00 RECQL (0.60) RECQLHPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL20456508 0.81 MEN1 (0.81) RECQLHPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL20456509 0.81 MEN1 (0.81) RECQLHPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL6097513 0.79 MAPT (0.58) RECQLHPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL6095640 0.77 MEN1 (0.65) RECQLHPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL19508692 0.76 CTSL (0.73) RECQLMEN1KMT2ACYP1A2PDE4D
SCHEMBL4176326 0.76 RECQL (0.68) RECQLHPGDALDH1A1SMN1; SMN2KDM4E
SCHEMBL4176324 0.76 RECQL (0.68) RECQLHPGDALDH1A1SMN1; SMN2KDM4E
SCHEMBL4188471 0.74 KDM4E (0.73) RECQLHPGDALDH1A1SMN1; SMN2KDM4E
SCHEMBL4188465 0.74 KDM4E (0.73) RECQLHPGDALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9949980-B2 Drugs to prevent HPV infection WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2018-04-24 US disclosed
US-20150297602-A1 DRUGS TO PREVENT HPV INFECTION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-10-22 US disclosed
US-9066951-B2 Drugs to treat HPV infection WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-06-30 US disclosed
US-20110165220-A1 DRUGS TO PREVENT HPV INFECTION WISCONSIN ALUMNI RESEARCH FOUNDATION 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165220-A1 DRUGS TO PREVENT HPV INFECTION VHL, PHF13, CDKN1A RECQL 1939/4885HPGD 188/4885ALDH1A1 458/4885
US-20150297602-A1 DRUGS TO PREVENT HPV INFECTION VHL, PHF13, CDKN1A RECQL 1939/4885HPGD 188/4885ALDH1A1 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.